Видео ютуба по тегу Non-Bcma

FAQs on Non-BCMA-Targeted Bispecific Antibodies in Multiple Myeloma
FAQs on Non-BCMA-Targeted Bispecific Antibodies in Multiple Myeloma
Innovative Therapy in Multiple Myeloma: Monoclonal Antibodies and BCMA and Non-BCMA Options
Innovative Therapy in Multiple Myeloma: Monoclonal Antibodies and BCMA and Non-BCMA Options
Секвенирование иммунотерапевтических препаратов, нацеленных на BCMA и GPRC5D, при множественной м...
Секвенирование иммунотерапевтических препаратов, нацеленных на BCMA и GPRC5D, при множественной м...
Extending the myeloma arena beyond BCMA
Extending the myeloma arena beyond BCMA
Overcoming BCMA loss in myeloma cells
Overcoming BCMA loss in myeloma cells
Promise of GPRC5D-targeted CAR-T therapies in multiple myeloma
Promise of GPRC5D-targeted CAR-T therapies in multiple myeloma
Анито-цел (CAR-T-терапия на основе BCMA): не выявлено случаев отсроченной нейротоксичности | Ната...
Анито-цел (CAR-T-терапия на основе BCMA): не выявлено случаев отсроченной нейротоксичности | Ната...
Phase I study of ABBV-383, a BCMA×CD3 bispecific antibody, in R/R myeloma
Phase I study of ABBV-383, a BCMA×CD3 bispecific antibody, in R/R myeloma
The movement of BCMA-directed therapies to earlier lines in myeloma treatment
The movement of BCMA-directed therapies to earlier lines in myeloma treatment
MM: Are anti-BCMA immunotherapies ready for the frontline?
MM: Are anti-BCMA immunotherapies ready for the frontline?
Can a patient use a different CAR-T target after receiving BCMA directed therapy?
Can a patient use a different CAR-T target after receiving BCMA directed therapy?
CAR T-cell therapy treating myeloma
CAR T-cell therapy treating myeloma
What non-cellular immunotherapies are in development for multiple myeloma?
What non-cellular immunotherapies are in development for multiple myeloma?
How do I treat patients with RRMM after failure of BCMA-targeted therapies?
How do I treat patients with RRMM after failure of BCMA-targeted therapies?
Immunotherapeutics against multiple myeloma: it's all about BCMA
Immunotherapeutics against multiple myeloma: it's all about BCMA
BINI | Makeup Transformation Challenge
BINI | Makeup Transformation Challenge
Biallelic BCMA loss causes anti-BCMA CAR-T resistance in myeloma
Biallelic BCMA loss causes anti-BCMA CAR-T resistance in myeloma
First-in-human trial of an anti-BCMA ADC for R/R myeloma
First-in-human trial of an anti-BCMA ADC for R/R myeloma
Optimizing the Use of Anti-BCMA Therapy in MM
Optimizing the Use of Anti-BCMA Therapy in MM